Patent ID: 7960387

Claim:
A medicament comprising a compound of formula (I), or a salt, or a solvate, or a solvate of a salt thereof, in which Ar represents aryl which may be substituted by 1 to 3 substituents, where the substituents are selected independently of one another from the group consisting of alkyl, alkoxy, formyl, carboxyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxyl, amino, alkylamino, aminocarbonyl and nitro, where alkyl may be substituted by 1 to 3 substituents, where the substituents are selected independently of one another from the group consisting of halogen, amino, alkylamino, hydroxyl and aryl, or two of the substituents on the aryl radical together with the carbon atoms to which they are attached form a 1,3-dioxolane, a cyclopentane ring or a cyclohexane ring, and any third substituent present is selected independently therefrom from the group mentioned, R 1 represents hydrogen, alkyl, alkoxy, cyano, halogen, nitro or trifluoromethyl, R 2 represents hydrogen, alkyl, alkoxy, cyano, halogen, nitro or trifluoromethyl, R 3 represents alkyl, alkoxy, cyano, halogen, nitro or trifluoromethyl or one of the radicals R 1 , R 2 and R 3 represents hydrogen, alkyl, alkoxy, cyano, halogen, nitro or trifluoromethyl and the other two together with the carbon atoms to which they are attached form a 1,3-dioxolane, a cyclopentane ring or a cyclohexane ring, R 4 represents hydrogen or alkyl, R 5 represents hydrogen or alkyl, or the radicals R 4 and R 5 are attached to carbon atoms directly opposing each other in the piperazine ring and form a methylene bridge which is optionally substituted by 1 or 2 methyl groups, in combination with a further active compound.